STING1 and neoplasm: Finally, combination nanotherapeutics based on the activation of the cGAS–STING signaling pathway have been used in tumor targeting therapy, including emerging strategies combining nanoformulated agonists with chemotherapy, radiotherapy, as well as other immunomodulation methods.401